BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 366325)

  • 1. [Evolution towards generalization and cancer of a muco-cutaneous leishmaniasis treated with corticoids. (Report of a Chadian case) (author's transl)].
    Derrien JP; Dedet JP; Vedy J; Delpy P; Sirol J
    Med Trop (Mars); 1978; 38(4):447-51. PubMed ID: 366325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous leishmaniasis followed by kala-azar in an adult in the province of Teramo (Abruzzi)].
    Pampiglione S
    Parassitologia; 1971; 13(1):231-9. PubMed ID: 5152939
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrence of kala-azar associated with post-kala-azar dermal leishmaniasis.
    Sen Gupta PC; Mukherjee AM
    J Indian Med Assoc; 1968 Jan; 50(1):1-5 passim. PubMed ID: 5668350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leishmaniasis (kala-azar, oriental sore, South American leishmaniasis)].
    Malamos B
    Wien Z Inn Med; 1967; 48(6):209-21. PubMed ID: 5630155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mucocutaneous leishmaniasis in otorhinolaryngology].
    Patuano E; Carrat X; Drouet Y; Barnabé D; Vincey P; Berthelot B
    Ann Otolaryngol Chir Cervicofac; 1993; 110(7):415-9. PubMed ID: 8085723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
    Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of visceral leishmaniasis with a difficult parasitological diagnosis and unexpected complications (author's transl)].
    Gendron Y; Laroche R; Sirol J
    Med Trop (Mars); 1978; 38(4):443-5. PubMed ID: 732560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of leishmaniasis (author's transl)].
    Barabe P
    Med Trop (Mars); 1981; 41(6):599-605. PubMed ID: 7339417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate].
    Amato V; Amato J; Nicodemo A; Uip D; Amato-Neto V; Duarte M
    Ann Dermatol Venereol; 1998 Aug; 125(8):492-5. PubMed ID: 9747313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].
    Morin D; Dumas ML; Valette H; Dumas R
    Arch Fr Pediatr; 1991 May; 48(5):349-51. PubMed ID: 1859238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
    Toran KC; Sah SP; Joshi A; Rani S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visceral and cutaneous leishmaniasis].
    Aulepp H; Gartmann H; Steigleder GK
    Z Hautkr; 1975 May; 50(9):355-64. PubMed ID: 52950
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneo-visceral leishmaniasis: a new opportunistic infection in patients infected by HIV].
    Botella Estrada R; Sanmartín Jiménez O; Febrer Bosch MI; Aliaga Boniche A; Salavert Lleti M; Roig Rico P; Nieto García A; Navarro Ibañez V
    Med Cutan Ibero Lat Am; 1990; 18(2):119-23. PubMed ID: 2214938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does the "leishmanian disease" exist? Apropos of the first case of so called sudanese kala-azar in Chad].
    Sirol J; Vedy J
    Nouv Presse Med; 1972 May; 1(20):1337-40. PubMed ID: 5035878
    [No Abstract]   [Full Text] [Related]  

  • 17. A case report of visceral leishmaniasis in the Tharaka District, Kenya.
    Pelizzi M; Verna M; Vanelli M
    Acta Biomed; 2006 Aug; 77(2):103-5. PubMed ID: 17172190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmaniasis of the nose caused by different species of Leishmania in the Sudan. Distinguishing features of the different clinical forms.
    el-Hassan AM; Yagi HI; Zijlstra EE; el-Kadarow AI
    Trop Geogr Med; 1994; 46(1):33-6. PubMed ID: 8165735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of visceral leishmaniasis (Kala-Azar). Side effects during the treatment with pentamidine].
    Lichey J; Linderer T; Dissmann T
    MMW Munch Med Wochenschr; 1979 May; 121(19):665-6. PubMed ID: 112393
    [No Abstract]   [Full Text] [Related]  

  • 20. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.